Michèle Kujas

Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article.

Luc Taillandier, Johan Pallud, Laurent Capelle, 2013, Journal of neurosurgery.

Dynamic history of low‐grade gliomas before and after temozolomide treatment

Laurent Capelle, Emmanuel Mandonnet, Hugues Duffau, 2007, Annals of neurology.

Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas

Luc Taillandier, Johan Pallud, Damien Galanaud, 2006, Annals of neurology.

Two types of chromosome 1p losses with opposite significance in gliomas

Olivier Delattre, Caroline Brennetot, Alain Aurias, 2005, Annals of neurology.

BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas

Emmanuel Barillot, Jean-Yves Delattre, Olivier Delattre, 2007, International journal of cancer.

OLIG2 as a specific marker of oligodendroglial tumour cells

Jean-Yves Delattre, Bernard Zalc, K. Hoang-Xuan, 2001, The Lancet.

Prognostic significance of imaging contrast enhancement for WHO grade II gliomas.

Luc Taillandier, Johan Pallud, Laurent Capelle, 2009, Neuro-oncology.